Clinical Trials in North Carolina

Showing 6801-6820 of 20,428 trials

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

NCT00406549

To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.

Staphylococcus Aureus

Solventum US LLC2,000 participantsStarted Dec 2006

Phoenix, Arizona, United States • Los Angeles, California, United States • Decatur, Georgia, United States +8 more locations

TERMINATEDPhase 341 miles

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

NCT04743804

This study will investigate the efficacy and safety of ravulizumab compared to placebo in adult participants with thrombotic microangiopathy (TMA) associated with a trigger. Participants will be randomized to receive either ravulizumab plus best supportive care or placebo plus best supportive care. The treatment period is 26 weeks followed by a 26-week off-treatment follow-up period.

Thrombotic Microangiopathy

Alexion Pharmaceuticals, Inc.16 participantsStarted Jun 2021

Tucson, Arizona, United States • Orange, California, United States • Washington D.C., District of Columbia, United States +94 more locations

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Find Trials by Condition in North Carolina

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

SMR Stemless Reverse Vs SMR Reverse Shoulder System

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

The MOTION Study - Treatment of LSS With the MILD Procedure

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Drug Screening System Method Comparison

Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force